Deep Track Capital, LP, Deep Track Biotechnology Master Fund, Ltd., and David Kroin filed Amendment No. 4 to their Schedule 13G with the SEC on November 16, 2026, disclosing a combined beneficial ownership position in Nurix Therapeutics, Inc. common stock as of September 30, …
Deep Track Capital, LP, Deep Track Biotechnology Master Fund, Ltd., and David Kroin filed Amendment No. 5 to Schedule 13G with the SEC on November 16, 2026, disclosing their beneficial ownership of common shares in Structure Therapeutics Inc. as of September 30, 2026.
Iroquois Capital Management LLC, Richard Abbe, and Kimberly Page filed Amendment No. 7 to a Schedule 13G with the SEC on November 16, 2026, disclosing their beneficial ownership of common stock in SCWorx Corp. as of September 30, 2026.
Iroquois Capital Management LLC, Richard Abbe, and Kimberly Page filed an amended Schedule 13G with the SEC on November 16, 2026, disclosing their beneficial ownership positions in Auddia Inc. (NASDAQ:AUUD) as of September 30, 2026.
Corebridge Financial, Inc. filed Amendment No. 3 to Schedule 13G on November 16, 2026, disclosing beneficial ownership of 4,000,000 shares, representing 9.5% of the outstanding securities of Carlyle Tactical Private Credit Fund as of September 30, 2026.
Highbridge Capital Management, LLC filed an amended Schedule 13G with the SEC on November 16, 2026, disclosing beneficial ownership of 2,619,799 ordinary shares of TOYO Co., Ltd (NASDAQ:TOYO), representing 5.8% of the outstanding class, with all shares issuable upon exercise of warrants held by …
Highbridge Capital Management, LLC filed a Schedule 13G with the SEC on November 16, 2026, disclosing beneficial ownership of Class A Ordinary Shares of Quantum Leap Acquisition Corp as of the triggering event date of September 30, 2026.
Highbridge Capital Management, LLC filed a Schedule 13G with the SEC on November 16, 2026, disclosing beneficial ownership of 629,816 Class A Ordinary Shares of AA Mission Acquisition Corp. II, a Cayman Islands exempted company, as of the triggering event date of September 30, …
Stonepine Capital Management, LLC and related reporting persons filed an amended Schedule 13G with the SEC on November 16, 2026, disclosing beneficial ownership of 579,912 shares of CalciMedica, Inc. common stock as of September 30, 2026.
Highbridge Capital Management, LLC filed a Schedule 13G with the SEC on November 16, 2026, disclosing a 7.0% beneficial ownership position in the ordinary shares of Starlink AI Acquisition Corporation as of September 30, 2026.